Mechanisms for gene overexpression due to mutated EGFR gene in GBM include N/C-terminal deletions and deletions of other exons which lead to an oncogenic EGFR protein in some mutations by keeping in the EGFR protein active conformation with an impact also on the RNA expression level of several other genes. The gene discussed is EGFR; the disease is glioblastoma.